Alliance Pharma Regulatory News (APH)

25 Apr 2008 09:02

Alliance Pharma PLC25 April 2008 For Immediate Release 25 April 2008 ALLIANCE PHARMA PLC ("Alliance Pharma" or "the Company") Master Investor 2008 Investment Show Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, ishosting a corporate exhibition stand at tomorrow's Master Investor 2008investment show in London. The Company's management team, including John Dawson,Chief Executive, and Richard Wright, Finance Director, look forward to welcominginvestors and potential investors to the stand and providing an insight intorecent progress at the Company. In its preliminary results for the year to 31 December 2007, Alliance Pharmareported sales up 6% at £18.2 million and commented that "the current year hasbegun well". Alliance Pharma's annual report, and further information about the Company, isavailable at the Company's website, www.alliancepharma.co.uk. The Master Investor 2008 show is taking place at the Business Design Centre,Islington, London, tomorrow, Saturday 26 April 2008. Further information isavailable at www.t1conferences.com/ . For further information: Alliance Pharma plc + 44 (0) 1249 466966 John Dawson, Chief ExecutiveRichard Wright, Finance Directorwww.alliancepharma.co.uk Buchanan Communications + 44 (0) 20 7466 5000Mark Court / Rebecca Skye Dietrich This information is provided by RNS The company news service from the London Stock Exchange